Digoxin toxicity: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
***Inhibits Na-K pump -> incr extracelluar K, incr intracellular Na -> incr intracellular Ca | ***Inhibits Na-K pump -> incr extracelluar K, incr intracellular Na -> incr intracellular Ca | ||
**Increases vagal tone | **Increases vagal tone | ||
***Can lead to | ***Can lead to [[Bradyarrhythmias]] (esp in young) | ||
**Increases automaticity | **Increases automaticity | ||
***Can lead to | ***Can lead to [[Tachyarrhythmias]] (esp in elderly) | ||
*Renally cleared | *Renally cleared | ||
*Hemodialysis does not work | *Hemodialysis does not work | ||
== Risk Factors == | === Risk Factors === | ||
#Electrolyte Imbalance | #Electrolyte Imbalance | ||
##[[Hypokalemia]], [[Hypomagnesemia]], [[Hypercalcemia]] | ##[[Hypokalemia]], [[Hypomagnesemia]], [[Hypercalcemia]] | ||
#Hypovolemia | #Hypovolemia | ||
#Renal insufficiency | #Renal insufficiency | ||
#Cardiac | #[[Cardiac Ischemia]] | ||
#[[Hypothyroidism]] | #[[Hypothyroidism]] | ||
#Meds | #Meds | ||
| Line 22: | Line 22: | ||
== Clinical Manifestations == | == Clinical Manifestations == | ||
===Cardiac=== | ===Cardiac=== | ||
#Syncope | #[[Syncope]] | ||
#Dysrhythmias | #Dysrhythmias | ||
##PVCs | ##PVCs | ||
##Bradycardia | ##[[Bradycardia]] | ||
##SVT w/ AV block | ##SVT w/ AV block | ||
##Junctional escape | ##Junctional escape | ||
| Line 31: | Line 31: | ||
#Digitalis Effect (seen with therapeutic levels; not indicative of toxicity) | #Digitalis Effect (seen with therapeutic levels; not indicative of toxicity) | ||
##T wave changes (flattening or inversion) | ##T wave changes (flattening or inversion) | ||
##QT | ##[[QT Interval Shortening]] | ||
##Scooped ST segments with depression in lateral leads | ##Scooped ST segments with depression in lateral leads | ||
##Increased U-wave amplitude | ##Increased U-wave amplitude | ||
| Line 37: | Line 37: | ||
===GI=== | ===GI=== | ||
#Often the earliest manifestation of toxicity | #Often the earliest manifestation of toxicity | ||
##Nausea/vomiting | ##[[Nausea/vomiting]] | ||
##Abdominal | ##[[Abdominal Pain]] | ||
===Neuro=== | ===Neuro=== | ||
#Confusion | #[[Confusion]] | ||
#Weakness | #[[Weakness]] | ||
#Visual disturbances | #Visual disturbances | ||
##Yellow halos | ##Yellow halos | ||
| Line 56: | Line 56: | ||
###If measure before this may be falsely elevated due to incomplete drug distribution | ###If measure before this may be falsely elevated due to incomplete drug distribution | ||
#Potassium level | #Potassium level | ||
##Acute toxicity: Degree of | ##Acute toxicity: Degree of [[Hyperkalemia]] correlates w/ degree of toxicity | ||
##Chronic toxicity: K+ may be normal/low (concomitant diuretic use) or high (renal failure) | ##Chronic toxicity: K+ may be normal/low (concomitant diuretic use) or high (renal failure) | ||
| Line 62: | Line 62: | ||
#CCB/BB toxicity | #CCB/BB toxicity | ||
#Clonidine toxicity | #Clonidine toxicity | ||
#Organophosphate | #[[Organophosphate pPisoning]] | ||
#Sick sinus syndrome | #Sick sinus syndrome | ||
==Work-Up== | ==Work-Up== | ||
#Dig level | #Dig level | ||
##Only useful prior to administration of Fab (otherwise becomes falsely elevated) | ##Only useful prior to administration of [[Fab]] (otherwise becomes falsely elevated) | ||
#Chemistry | #Chemistry | ||
#Urine output | #Urine output | ||
| Line 85: | Line 85: | ||
##Consider lower energy settings (25-50J) | ##Consider lower energy settings (25-50J) | ||
#Bradyarrhythmias (symptomatic) | #Bradyarrhythmias (symptomatic) | ||
##Atropine 0.5mg IV | ##[[Atropine]] 0.5mg IV | ||
##Pacing | ##[[Pacing]] | ||
#Ventricular dysrhythmias | #Ventricular dysrhythmias | ||
##[[Dilantin Load|Phenytoin]] | ##[[Dilantin Load|Phenytoin]] | ||
| Line 97: | Line 97: | ||
===[[Hyperkalemia]]=== | ===[[Hyperkalemia]]=== | ||
#Treat with Fab, not with usual meds | #Treat with [[Fab]], not with usual meds | ||
##Once Fab is given hyperkalemia will rapidly correct | ##Once Fab is given hyperkalemia will rapidly correct | ||
#If Fab unavailable and hyperkalemia is life-threatening then treat with: | #If [[Fab]] unavailable and hyperkalemia is life-threatening then treat with: | ||
##Glucose-insulin | ##Glucose-insulin | ||
##Sodium bicarb | ##Sodium bicarb | ||
##Kayexelate | ##Kayexelate | ||
## | ##Dialysis | ||
##Calcium (controversial: some say dangerous, others say not) | ##Calcium (controversial: some say dangerous, others say not) | ||
| Line 120: | Line 120: | ||
==Disposition== | ==Disposition== | ||
*Admit for signs of toxicity or history of large ingested dose; admit to ICU if Fab given | *Admit for signs of toxicity or history of large ingested dose; admit to ICU if [[Fab]] given | ||
*Discharge after 12hr observation if asymptomatic after accidental overdose | *Discharge after 12hr observation if asymptomatic after accidental overdose | ||
Revision as of 21:42, 31 March 2012
Background
- Mechanism of action
- Positive inotropic effect
- Inhibits Na-K pump -> incr extracelluar K, incr intracellular Na -> incr intracellular Ca
- Increases vagal tone
- Can lead to Bradyarrhythmias (esp in young)
- Increases automaticity
- Can lead to Tachyarrhythmias (esp in elderly)
- Positive inotropic effect
- Renally cleared
- Hemodialysis does not work
Risk Factors
- Electrolyte Imbalance
- Hypovolemia
- Renal insufficiency
- Cardiac Ischemia
- Hypothyroidism
- Meds
- CCBs, amiodarone
Clinical Manifestations
Cardiac
- Syncope
- Dysrhythmias
- PVCs
- Bradycardia
- SVT w/ AV block
- Junctional escape
- Ventricular dysrhythmia, including bidirectional V-tach (esp in chronic toxicity)
- Digitalis Effect (seen with therapeutic levels; not indicative of toxicity)
- T wave changes (flattening or inversion)
- QT Interval Shortening
- Scooped ST segments with depression in lateral leads
- Increased U-wave amplitude
GI
- Often the earliest manifestation of toxicity
Neuro
Diagnosis
- Must use H&P and labs in combination; no single element excludes or confirms the dx
- Digoxin level
- Normal = 0.5-2 ng/mL (ideal = 0.7-1.1)
- May have toxicity even with "therapeutic" levels (esp w/ chronic toxicity)
- Measure at least 6hr after acute ingestion (if stable); immediately for chronic ingestion
- If measure before this may be falsely elevated due to incomplete drug distribution
- Normal = 0.5-2 ng/mL (ideal = 0.7-1.1)
- Potassium level
- Acute toxicity: Degree of Hyperkalemia correlates w/ degree of toxicity
- Chronic toxicity: K+ may be normal/low (concomitant diuretic use) or high (renal failure)
DDX
- CCB/BB toxicity
- Clonidine toxicity
- Organophosphate pPisoning
- Sick sinus syndrome
Work-Up
- Dig level
- Only useful prior to administration of Fab (otherwise becomes falsely elevated)
- Chemistry
- Urine output
- ECG (serial)
Treatment
- Digoxin Immune Fab
- Activated Charcoal
- Questionable efficacy
- Only an adjunctive tx; NOT an alternative to fab fragment therapy
- Consider only if present within 1 hr of ingestion
- 1g/kg (max 50g)
Dysrhythmias
- Digoxin Immune Fab is the agent of choice for all dysrhythmias!
- Cardioversion should only be used as a last resort (may precipitate V-Fib)
- Consider lower energy settings (25-50J)
- Bradyarrhythmias (symptomatic)
- Ventricular dysrhythmias
Hyperkalemia
- Treat with Fab, not with usual meds
- Once Fab is given hyperkalemia will rapidly correct
- If Fab unavailable and hyperkalemia is life-threatening then treat with:
- Glucose-insulin
- Sodium bicarb
- Kayexelate
- Dialysis
- Calcium (controversial: some say dangerous, others say not)
Hypokalemia
- Chronic intoxication
- Raise level to 3.5-4
- Acute intoxication
- Do not treat (likely that potassium level is rapidly rising)
Hypomagnesemia
- Treat with 1-2g over 10-20 min
- Monitor for resp depresion
- Avoid in pts with:
- Renal failure
- Bradydysrhythmias/conduction blocks
Disposition
- Admit for signs of toxicity or history of large ingested dose; admit to ICU if Fab given
- Discharge after 12hr observation if asymptomatic after accidental overdose
See Also
Source
- Rosen's
- Tintinalli
